Halma plc acquisition of Medicel AG and Robutec GmbH

 

Client and Buyer:  Halma PLC

Halma is a UK based global group of life-saving technology companies.  Halma is a member of the FTSE-100 with shares traded on the London Stock Exchange (HLMA.L).  Halma is organized into three sectors: Safety, Medical and Environmental & Analysis. 

 

Seller:  Medicel AG and Robutec GmbH

Medicel is a leader in the design and manufacture of single-use injector devices for Intra

Ocular Lenses (IOL) used for cataract surgery and also manufactures phacoemulsification products used in the same procedure. Robutec is a specialist medical device assembly and packaging business and is Medicel’s largest supplier.

 

Transaction Details:

Medicel will join Halma’s Health and Analysis sector within the Health Optics sub-sector which already includes Keeler, Volk and Riester, further expanding Halma’s footprint in ophthalmic diagnostic and surgical instrumentation.  The initial cash consideration is CHF70.0 million (£46.6 million) and is adjustable, CHF for CHF, based on the level of net tangible assets at closing.

 

Broker/Dealer:  OEM Capital

Completion:  March 2011

Copyright © 2021 American Corporate Services, All rights reserved.  Securities are offered by registered representatives of and transacted through Hamilton Grant, LLC, member FINRA and SIPC.  For more information on Hamilton Grant visit  www.hamiltongrant.com. Hamilton Grant and ACS are not affiliated.  
 
Site development by LMS Productions